Purchase Order 75D30118P02041
Award Date 8/1/18
Potential Completion Date 7/31/19
Potential Value $150K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $7,521,000.00, was issued by the Centers for Disease Control and Prevention (CDC) to Protein Sciences Corp, a for-profit manufacturer, to conduct research, development, manufacturing, and testing of vaccine candidates, antigens, proteins, seed lots, and assays to support medical countermeasure preparedness against influenza strains and COVID-19. The award is part of the Department of Health and Human Services' (HHS) Office of the Assistant Secretary for...
- The National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), awarded a $664,000.65 firm fixed price purchase order to Vigene Biosciences, Inc., a minority-owned small business, for the delivery of clinical grade virus vectors. The award was made through a sole source acquisition process under Federal Acquisition Regulation (FAR) Part 12 for commercial items. The vectors are needed to support ongoing research at NIAID's Laboratory...
- The Centers for Disease Control and Prevention (CDC) awarded a firm-fixed-price purchase order contract worth $87,600 to Federon Procurement Solutions, a minority-owned, self-certified small disadvantaged business in Alexandria, Virginia. The contract is for the bulk production of oligonucleotides and synthetic genes to support the development of Candidate Vaccine Viruses (CVVs) at the CDC Influenza Division. This requirement was originally posted as an $87,600 Request for Quotations (RFQ)...
- This is a $748,885 firm-fixed-price contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Access To Advanced Health Institute (AAHI), a nonprofit biotech research institute based in Seattle, Washington. The contract is for research and development of intranasal administration of RNA vaccines against respiratory pathogens. The contract was awarded under an Ease Broad Agency Announcement (EZ-BAA) issued by the Division of Research, Innovation, and...
- This is a $149,996 firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Vitan-Biotech LLC, a minority-owned, for-profit biotechnology company, for RESEARCH AND DEVELOPMENT UNDER SBIR. The award has no set-aside designation and the performance location is in Littleton, Colorado. Vitan-Biotech has previously received several NIH grants for research related to glycobiology, immunotherapeutics, nanobodies, and membrane protein analysis, which align...
- This is a federal contract award to Protein Sciences Corp, a for-profit vaccine manufacturer, by the U.S. Department of Health and Human Services' (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR). The $2,146,389.00 firm fixed-price contract is a delivery order under ASPR's Pandemic Influenza Preparedness and Response 2016-2021 master IDIQ contract. The purpose of the award is for Protein Sciences to manufacture 1 bulk lot of an H7 vaccine. No set-aside designation was...
- This $1,000,000 firm-fixed-price SBIR Phase II contract was awarded by the Centers for Disease Control and Prevention (CDC) to Antagen Biosciences Inc., a minority-owned, small disadvantaged business. The contract is for research and development of an engineered HIV envelope glycoprotein and novel vaccine adjuvants to enhance the efficacy of vaccines against infectious and immune-mediated diseases. This award is part of Antagen's broader portfolio of SBIR contracts, including prior awards from...
- The Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a $599,980 firm fixed price contract to Tendel Therapies, Inc., a small business, for research and development services related to genetic adjuvants to promote durable anti-influenza stem antibodies in older adults. This contract was awarded under the NIH and Centers for Disease Control and Prevention's Small Business Innovation Research (SBIR) program,...
- This federal contract award was issued by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) to Protein Sciences Corp, a for-profit manufacturer, under ASPR's Pandemic Influenza Preparedness and Response 2016-2021 master Indefinite Delivery/Indefinite Quantity (IDIQ) contract. The $357,198.29 Firm Fixed Price delivery order supports Protein Sciences' research, development, manufacturing, and testing of vaccine candidates, antigens,...
- This federal contract award to Protein Sciences Corp, a for-profit manufacturer, was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS). The $14,675 firm-fixed-price purchase order is for the provision of tested influenza virus proteins. The contract does not have a set-aside designation. Protein Sciences has received multiple previous federal contract awards from the HHS Office of the Assistant Secretary...